The Goldman Sachs Group Trims agilon health (NYSE:AGL) Target Price to $25.00
Agilon health (NYSE:AGL – Free Report) had its price objective cut by The Goldman Sachs Group from $29.00 to $25.00 in a research note published on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. Other research analysts have also issued research reports about the company. Truist Financial reduced their price […]